NASDAQ:ISPC iSpecimen (ISPC) Stock Price, News & Analysis → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free ISPC Stock Alerts $0.28 +0.00 (+0.86%) (As of 05:12 PM ET) Add Compare Share Share Today's Range$0.28▼$0.2950-Day Range$0.21▼$0.4852-Week Range$0.20▼$1.89Volume125,245 shsAverage Volume673,386 shsMarket Capitalization$2.63 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Get iSpecimen alerts: Email Address Ad Stansberry ResearchMysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. About iSpecimen Stock (NASDAQ:ISPC)iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.Read More ISPC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ISPC Stock News HeadlinesApril 25, 2024 | globenewswire.comiSpecimen to Report First Quarter 2024 Financial Results on May 7, 2024April 18, 2024 | msn.comU.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.06%April 25, 2024 | Stansberry Research (Ad)Mysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.March 16, 2024 | seekingalpha.comiSpecimen Inc. (ISPC) Q4 2023 Earnings Call TranscriptMarch 16, 2024 | investing.comEarnings call: iSpecimen reports full-year 2023 results, aims for 2024 profitabilityMarch 15, 2024 | sg.finance.yahoo.comNvidia GTC AI conference: What to watchMarch 15, 2024 | finance.yahoo.comiSpecimen Inc. (NASDAQ:ISPC) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | finance.yahoo.comiSpecimen Full Year 2023 Earnings: Misses ExpectationsApril 25, 2024 | Stansberry Research (Ad)Mysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.March 14, 2024 | finanznachrichten.deiSpecimen Inc: iSpecimen Reports Full Year 2023 ResultsMarch 14, 2024 | globenewswire.comiSpecimen Reports Full Year 2023 ResultsMarch 13, 2024 | benzinga.comiSpecimen: Q4 Earnings InsightsMarch 13, 2024 | nz.finance.yahoo.comFed rate cuts likely coming after June -strategistMarch 12, 2024 | globenewswire.comiSpecimen Reschedules Full Year 2023 Earnings Release and Conference CallMarch 5, 2024 | globenewswire.comiSpecimen to Report Full Year 2023 Financial Results on March 13, 2024January 23, 2024 | finanznachrichten.deiSpecimen Inc: iSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based ResearchJanuary 23, 2024 | markets.businessinsider.comISpecimen, TriMetis Life Sciences Announce Partnership For Tissue ResearchJanuary 23, 2024 | finance.yahoo.comiSpecimen and TriMetis Life Sciences Announce Strategic Partnership to Help Transform Tissue-Based ResearchJanuary 18, 2024 | finance.yahoo.comiSpecimen to Participate in Maxim Group Healthcare IT Virtual Conference, January 24 & 25, 2024December 21, 2023 | morningstar.comiSpecimen Inc ISPCDecember 7, 2023 | finance.yahoo.comiSpecimen Strengthens Global Oncology Biospecimen OfferingNovember 5, 2023 | finance.yahoo.comiSpecimen Inc. (NASDAQ:ISPC) Q3 2023 Earnings Call TranscriptNovember 2, 2023 | msn.comiSpecimen GAAP EPS of -$0.23 beats by $0.12, revenue of $2.78M beats by $0.55MNovember 2, 2023 | finance.yahoo.comiSpecimen Reports Third Quarter 2023 Financial and Operating ResultsOctober 26, 2023 | finance.yahoo.comiSpecimen Expands Proprietary Provider Network to Help Advance Infectious Disease ResearchOctober 23, 2023 | msn.comiSpecimen expects Q3 revenue above consensusOctober 2, 2023 | bizjournals.comBiotech layoffs 2023: In Q3, 19 Boston-area biotechs made cutsSee More Headlines Receive ISPC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iSpecimen and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/13/2024Today4/25/2024Next Earnings (Estimated)5/02/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Commercial physical research Sub-IndustryN/A Current SymbolNASDAQ:ISPC CUSIPN/A CIK1558569 Webispecimen.com Phone781-301-6700FaxN/AEmployees53Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.23) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-11,100,000.00 Net Margins-111.81% Pretax Margin-111.79% Return on Equity-80.37% Return on Assets-61.99% Debt Debt-to-Equity RatioN/A Current Ratio1.36 Quick Ratio1.36 Sales & Book Value Annual Sales$9.93 million Price / Sales0.26 Cash FlowN/A Price / Cash FlowN/A Book Value$1.07 per share Price / Book0.26Miscellaneous Outstanding Shares9,370,000Free Float6,309,000Market Cap$2.63 million OptionableNot Optionable Beta1.69 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMs. Tracy Wilson Curley (Age 62)CEO, CFO, Treasurer & Director Comp: $437.5kMr. Benjamin Bielak (Age 54)Chief Information Officer & Secretary Comp: $391.2kMs. Carly LejnieksVice President of MarketingMs. Annette ArnoldVice President of Sales & Business DevelopmentMr. David Wages M.D.Ph.D., Chief Medical OfficerMr. Eric LangloisChief Revenue OfficerMr. Evan CoxSenior Vice President of Strategy & InnovationMore ExecutivesKey CompetitorsNovaBay PharmaceuticalsNYSE:NBYENDRA Life SciencesNASDAQ:NDRAAgile TherapeuticsNASDAQ:AGRXTransCode TherapeuticsNASDAQ:RNAZOnconetixNASDAQ:ONCOView All CompetitorsInsidersBenjamin BielakBought 18,000 shares on 9/14/2023Total: $12,960.00 ($0.72/share)Tracy CurleyBought 4,400 shares on 5/31/2023Total: $5,500.00 ($1.25/share)View All Insider Transactions ISPC Stock Analysis - Frequently Asked Questions How have ISPC shares performed in 2024? iSpecimen's stock was trading at $0.5006 on January 1st, 2024. Since then, ISPC shares have decreased by 41.8% and is now trading at $0.2911. View the best growth stocks for 2024 here. Are investors shorting iSpecimen? iSpecimen saw a drop in short interest in April. As of April 15th, there was short interest totaling 70,900 shares, a drop of 84.6% from the March 31st total of 459,500 shares. Based on an average trading volume of 814,600 shares, the days-to-cover ratio is currently 0.1 days. Currently, 1.3% of the company's shares are short sold. View iSpecimen's Short Interest. When is iSpecimen's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our ISPC earnings forecast. How were iSpecimen's earnings last quarter? iSpecimen Inc. (NASDAQ:ISPC) posted its quarterly earnings results on Wednesday, March, 13th. The company reported ($0.34) earnings per share for the quarter. The firm had revenue of $2.58 million for the quarter. iSpecimen had a negative net margin of 111.81% and a negative trailing twelve-month return on equity of 80.37%. When did iSpecimen IPO? iSpecimen (ISPC) raised $20 million in an IPO on Thursday, June 17th 2021. The company issued 2,200,000 shares at $8.00-$10.00 per share. ThinkEquity (a division of Fordham Financial Management) acted as the underwriter for the IPO. How do I buy shares of iSpecimen? Shares of ISPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ISPC) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeThe World's First "$20 Trillion Drug?"Behind the MarketsThe only accurate crypto trading system I know …Weiss RatingsFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iSpecimen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
